Notable
SNK01 · Moderate Alzheimer's Disease
Primary completion pushed from Dec 2026 to Mar 2028
Also in this update: Study completion pushed from Jun 2027 to Jun 2028
NKGen Biotech, Inc.Phase 1/2 NCT06189963 Registry history of NCT06189963 on ClinicalTrials.gov (opens the registry)